CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
7.7125
5.73%
Market Trading Hours* (UTC) Opens on Tuesday at 07:00

Mon - Fri: 07:00 - 15:30

  • Summary
  • Historical Data
Trading сonditions
Spread 0.0750
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.025295 %
Charges from full value of position ($-4.81)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.025295%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.003377 %
Charges from full value of position ($0.64)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003377%
Overnight fee time 21:00 (UTC)
Min traded quantity 0.1
Currency GBP
Margin 5%
Stock exchange United Kingdom of Great Britain and Northern Ireland
Commission on trade 0%

Key Stats
Prev. Close 8.1815
Open 8.042
1-Year Change -53.94%
Day's Range 7.6175 - 8.1865
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jul 12, 2024 8.1815 -0.2245 -2.67% 8.4060 8.6060 8.0715
Jul 11, 2024 8.3715 0.3645 4.55% 8.0070 8.4560 7.7970
Jul 10, 2024 7.8020 0.0350 0.45% 7.7670 7.8970 7.4125
Jul 9, 2024 7.5325 -1.3330 -15.04% 8.8655 8.9205 6.5190
Jul 8, 2024 11.7610 0.2700 2.35% 11.4910 11.7810 11.4910
Jul 5, 2024 11.6210 0.0800 0.69% 11.5410 11.9705 11.5110
Jul 4, 2024 11.7710 0.2000 1.73% 11.5710 11.8505 11.4910
Jul 3, 2024 11.3915 -0.6190 -5.15% 12.0105 12.1305 11.3915
Jul 2, 2024 12.0705 -0.0695 -0.57% 12.1400 12.2200 11.8805
Jul 1, 2024 12.2400 -0.1400 -1.13% 12.3800 12.5595 11.9205
Jun 28, 2024 12.1800 -0.5590 -4.39% 12.7390 12.7495 12.1800
Jun 27, 2024 12.8690 -0.1895 -1.45% 13.0585 13.1985 12.7690
Jun 26, 2024 13.0590 0.4895 3.89% 12.5695 13.0985 12.4695
Jun 25, 2024 12.6195 -0.2195 -1.71% 12.8390 12.8590 12.2700
Jun 24, 2024 13.0090 -0.0995 -0.76% 13.1085 13.1685 12.7490
Jun 21, 2024 13.3980 0.6990 5.50% 12.6990 13.4080 12.5895
Jun 20, 2024 12.7490 0.1395 1.11% 12.6095 12.9190 12.4995
Jun 19, 2024 12.5595 0.0900 0.72% 12.4695 12.8290 12.3400
Jun 18, 2024 12.5895 -0.1495 -1.17% 12.7390 12.8590 12.5095
Jun 17, 2024 12.8190 -0.2095 -1.61% 13.0285 13.1085 12.7290

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Indivior Company profile

About Indivior PLC

Indivior PLC is a United Kingdom-based pharmaceutical company. The Company is engaged in developing medicines to treat addiction and serious mental illnesses. It focuses to build a portfolio of opioid dependence treatments. It has a pipeline of product candidates designed to address other chronic conditions and cooccurring disorders of addiction, including alcohol use disorder. Its product pipeline focuses on development and discovery of non-opioid treatment strategies for opioid use disorder (OUD), as well as new therapies to address the needs of people suffering from alcohol, stimulant and cannabis use disorders. Its pipeline products include INDV-3000 - Selective Dopamine D3-receptor Antagonist, RBP-6000 - Buprenorphine XR injection, Buprenorphine/ Naloxone Sublingual Film, Buprenorphine/ Naloxone Sublingual Tablet and Buprenorphine Sublingual Tablet, among others. Its portfolio of products is available in more than 40 countries.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Indivior PLC revenues increased 22% to $791M. Net income totaled $205M vs. loss of $148M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Other operating income increase from $0K to $32M (income), Selling/General/Admin. Expense, decrease of 5% to $192M (expense).

Industry: Proprietary & Advanced Pharmaceuticals

234 Bath Road
SLOUGH
BERKSHIRE SL1 4EE
GB

People also watch

US100

20,420.30 Price
+0.440% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

BTC/USD

63,740.15 Price
+5.880% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

XRP/USD

0.54 Price
+1.010% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

ETH/USD

3,442.75 Price
+7.390% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

Still looking for a broker you can trust?

Join the 630,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading